Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters - Transcription factor FKHR binds the insulin response sequence

被引:102
作者
Ayala, JE
Streeper, RS
Desgrosellier, JS
Durham, SK
Suwanichkul, A
Svitek, CA
Goldman, JK
Barr, FG
Powell, DR
O'Brien, RM
机构
[1] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[3] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
D O I
10.2337/diabetes.48.9.1885
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Because overexpression of the glucose-6-phosphatase catalytic subunit (G-6-Pase) in both type 1 and type 2 diabetes may contribute to the characteristic increased rate of hepatic glucose production, we have investigated whether the insulin response unit (IRU) identified in the mouse G-6-Pase promoter is conserved in the human promoter. A series of human G-6-Pase-chloramphenicol acetyltransferase (CAT) fusion genes was transiently transfected into human HepG2 hepatoma cells, and the effect of insulin on basal CAT expression was analyzed. The results suggest that the IRU identified in the mouse promoter is conserved in the human promoter, but that an upstream multimerized insulin response sequence (IRS) motif that is only found in the human promoter appears to be functionally inactive. The G-6-Pase IRU comprises two distinct promoter regions, designated A and B, Region B contains an TRS, whereas region A acts as an accessory element to enhance the effect of insulin, mediated through region B, on basal G-6-Pase gene transcription. We have previously shown that the accessory factor binding region A is hepatocyte nuclear factor-1, and we show here that the forkhead protein FKHR is a candidate for the insulin-responsive transcription factor binding region B.
引用
收藏
页码:1885 / 1889
页数:5
相关论文
共 20 条
[1]   Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states - Gene structure and 5'-flanking sequence [J].
Argaud, D ;
Zhang, Q ;
Pan, WS ;
Maitra, S ;
Pilkis, SJ ;
Lange, AJ .
DIABETES, 1996, 45 (11) :1563-1571
[2]  
BARZILAI N, 1993, J BIOL CHEM, V268, P25019
[3]   Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].
Brunet, A ;
Bonni, A ;
Zigmond, MJ ;
Lin, MZ ;
Juo, P ;
Hu, LS ;
Anderson, MJ ;
Arden, KC ;
Blenis, J ;
Greenberg, ME .
CELL, 1999, 96 (06) :857-868
[4]   STRUCTURAL CHARACTERIZATION OF THE FKHR GENE AND ITS REARRANGEMENT IN ALVEOLAR RHABDOMYOSARCOMA [J].
DAVIS, RJ ;
BENNICELLI, JL ;
MACINA, RA ;
NYCUM, LM ;
BIEGEL, JA ;
BARR, FG .
HUMAN MOLECULAR GENETICS, 1995, 4 (12) :2355-2362
[5]   FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter [J].
Durham, SK ;
Suwanichkul, A ;
Scheimann, AO ;
Yee, D ;
Jackson, JG ;
Barr, FB ;
Powell, DR .
ENDOCRINOLOGY, 1999, 140 (07) :3140-3146
[6]   MILD TYPE-2 DIABETES MARKEDLY INCREASES GLUCOSE CYCLING IN THE POSTABSORPTIVE STATE AND DURING GLUCOSE-INFUSION IRRESPECTIVE OF OBESITY [J].
EFENDIC, S ;
KARLANDER, S ;
VRANIC, M .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (06) :1953-1961
[7]   THE CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE-DEPENDENT AND THE GLUCOCORTICOID-DEPENDENT ENHANCERS ARE TARGETS FOR INSULIN REPRESSION OF TYROSINE AMINOTRANSFERASE GENE-TRANSCRIPTION [J].
GANSS, R ;
WEIH, F ;
SCHUTZ, G .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (07) :895-903
[8]   FUNCTIONAL-ANALYSIS OF GLUCOCORTICOID AND INSULIN-RESPONSE SEQUENCES IN THE RAT INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 PROMOTER [J].
GOSWAMI, R ;
LACSON, R ;
YANG, E ;
SAM, R ;
UNTERMAN, T .
ENDOCRINOLOGY, 1994, 134 (02) :736-743
[9]  
JACOBY DB, 1989, J BIOL CHEM, V264, P17623
[10]   Direct control of the Forkhead transcription factor AFX by protein kinase B [J].
Kops, GJPL ;
de Ruiter, ND ;
De Vries-Smits, AMM ;
Powell, DR ;
Bos, JL ;
Burgering, BMT .
NATURE, 1999, 398 (6728) :630-634